Ireneusz Fafara

Ireneusz Fafara currently works at ORLEN SA, as CEO & Chairman-Management Board from 2024, ORLEN Upstream Canada Ltd., as President-Management Board & CEO, Helix Immuno-Oncology SA, as Chairman-Management Board, 4cell Therapies SA, as President from 2020, and Polski Koncern Naftowy Orlen SA, as Partner.
Mr. Fafara also formerly worked at ORLEN Lietuva AB, as Chairman & Chief Executive Officer, Kompania Weglowa SA, as Chairman-Management Board from 2003 to 2005, Export Credit Insurance CJSC, as Chairman-Management Board from 2007 to 2009, Bank Gospodarstwa Krajowego SA, as Chairman-Management Board from 2007 to 2009, Energa SA, as Chairman-Supervisory Board, Helix BioPharma Corp., as Independent Director, Agencja Rynku Energii SA, as Member-Management Board from 1997 to 1998, PKO Bank Polski SA, as Member-Supervisory Board from 2009 to 2010, Grupa LOTOS SA, as Member-Supervisory Board from 2009 to 2010, National Health Fund, as Member-Supervisory Board from 2005 to 2008, Zaklad Ubezpieczen Spolecznych, as Vice President-Management Board from 1998 to 2007, and Rockbridge FIZ Bezpieczna Inwestycja 2, as Member-Supervisory Board from 2018 to 2024.
Mr. Fafara received his undergraduate degree from Cracow University of Economics.